Evaluation of chronic urticaria in patients with hashimoto thyroiditis

被引:36
作者
Kandeel, AA
Zeid, M
Helm, T
Lillie, MA
Donahue, E
Ambrus, JL
机构
[1] Kaleida Hlth Buffalo Gen Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Buffalo, NY 14203 USA
[2] Kaleida Hlth Buffalo Gen Hosp, Dept Pathol, Buffalo, NY 14203 USA
[3] Kaleida Hlth Millard Fillmore Hosp, Dept Allergy, Buffalo, NY 14203 USA
关键词
urticaria; autoimmunity; Hashimoto thyroiditis;
D O I
10.1023/A:1012288602962
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The coincidence of Hashimoto thyroiditis (HT) and chronic idiopathic urticaria (CIU) is a commonly observed phenomenon in western New York. Previous literature suggested that there may be a direct relationship between them. We undertook these studies to determine whether humoral or cell-mediated mechanisms might link HT and CIU. Skin biopsies from patients with CIU, with or without HT, were indistinguishable by light microscopy. No immune complex deposition was observed, although only the skin from patients with CIU and HT contained perivascular fibrin deposits. Similarly, inummohistochemical studies evaluating cellular expression of CD3, CD4, CD8, CD20, and CD68 failed to differentiate between CIU with or without HT. Analysis of VG restriction in thyroid tissue of patients with HT and the skin of patients with CIU and HT by in situ polymerase chain reaction failed to reveal any oligoclonal T-lymphocyte subpopulations. In contrast, only patients with CIU and HT had anti-Fc epsilon RI antibodies in their sera that could induce degranulation of normal basophils. Some sera from patients with CIU and HT caused degranulation of normal basophils in the absence of anti-FceRI. The factor causing basophil degranulation in these sera was not determined. Patients with CIU and HT failed to improve clinically with thyroid replacement therapy. All CIU patients were equally well managed with symptomatic therapies. In conclusion, HT likely represents a marker of other autoimmunity, rather than being a direct causative agent in CIU. Management of CIU, with or without HT and with or without anti-FceRI antibodies, should be the same. Future studies will have to examine whether cell-mediated responses participate in CIU, especially in association with HT.
引用
收藏
页码:335 / 347
页数:13
相关论文
共 40 条
[1]   PURIFICATION TO HOMOGENEITY OF A HIGH MOLECULAR-WEIGHT HUMAN B-CELL GROWTH-FACTOR - DEMONSTRATION OF SPECIFIC BINDING TO ACTIVATED B-CELLS - AND DEVELOPMENT OF A MONOCLONAL-ANTIBODY TO THE FACTOR [J].
AMBRUS, JL ;
JURGENSEN, CH ;
BROWN, EJ ;
FAUCI, AS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (04) :1319-1335
[2]   HIGH LEVELS OF BCL-2 PROTEIN IN CIRCULATING T-LYMPHOCYTES, BUT NOT B-LYMPHOCYTES, OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ARINGER, M ;
WINTERSBERGER, W ;
STEINER, CW ;
KIENER, H ;
PRESTERL, E ;
JAEGER, U ;
SMOLEN, JS ;
GRANINGER, WB .
ARTHRITIS AND RHEUMATISM, 1994, 37 (10) :1423-1430
[3]  
ATLUS P, 1993, AM J MED SCI, V306, P379
[4]  
BELFIORE A, 1987, MONOGR ALLERGY, V21, P215
[5]   T-CELL RECEPTOR V GENE USE IN AUTOIMMUNE THYROID-DISEASE - DIRECT ASSESSMENT BY THYROID ASPIRATION [J].
DAVIES, TE ;
CONCEPCION, ES ;
BENNUN, A ;
GRAVES, PN ;
TARJAN, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03) :660-666
[6]   Chronic autoimmune thyroiditis [J].
Dayan, CM ;
Daniels, GH .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :99-107
[7]   Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production [J].
DesaiMehta, A ;
Lu, LJ ;
RamseyGoldman, R ;
Datta, SK .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (09) :2063-2073
[8]   Steroid-resistant chronic urticaria associated with anti-thyroid microsomal antibodies in a nine-year-old boy [J].
Dreyfus, DH ;
Schocket, AL ;
Milgrom, H .
JOURNAL OF PEDIATRICS, 1996, 128 (04) :576-578
[9]   Comparative studies of functional and binding assays for IgG anti-FcεRIα (α-subunit) in chronic urticaria [J].
Ferrer, M ;
Kinét, JP ;
Kaplan, AP .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (05) :672-676
[10]  
FERRER M, 1998, J ALLERG CLIN I S515, V101